On the one hand you're saying Teva's filing is the same as some other company's ex-US generic lovenox and on the other hand claiming if approved they're infringing mnta's patents. I think the chances for an injunction are less than a Hail Mary pass from the 50 thrown by Johnny Damon. -)
Market Data 
Markets 
AI
